Open AccessTargeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM
Author(s) -
Ching-Ann Liu,
HorngJyh Harn,
Kuan-Pin Chen,
Jui-Hao Lee,
ShinnZong Lin,
TsungLang Chiu
Publication year - 2022
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2022/3236058
Subject(s) - medicine , pi3k/akt/mtor pathway , immunotherapy , chemotherapy , cancer research , oncology , discovery and development of mtor inhibitors , signal transduction , cancer , genetics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom